Verified, then logged.
Sun 22 Nov 2026 · 00:21 KST / 15:21 UTC한국어 | ENSearch /

08 / Industry · Analysis

MedInTech raises 33.8 billion won in Series C funding

The developer of AI robotic endoscopes plans to complete the jointly led round with additional investment before year-end.

MedInTech, a developer of AI robotic endoscopes for the digestive tract, said it had raised 33.8 billion won in Series C funding, according to AI Times.

AI Times reported that the company planned to complete the round with additional investment before year-end. The reported funding therefore represents a stage in the round rather than its final total.

The report described MedInTech's approach as combining robotic precision control and AI with gastrointestinal endoscopy. The financing and the technology are distinct parts of the account: the amount raised concerns the current round, while the product centres on how clinicians operate endoscopes.

Current funding and cumulative investment

According to AI Times, Atinum Investment and KB Investment jointly led the Series C round. The planned additional investment would bring the round to a close before year-end.

The report put MedInTech's cumulative funding at approximately 62.2 billion won. That figure describes investment raised over time and is separate from the 33.8 billion won reported for this round.

Precision control in gastrointestinal endoscopy

AI Times reported that gastrointestinal endoscopy has relied on manual operation by medical staff. MedInTech's development adds robotic precision control and AI to that operation.

The report identified the hardware as Intion S. Its account placed precision control and AI at the centre of the development, while the next financing step is the additional investment planned to complete the Series C round.